Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Ducreux

Showing results (1-10 of 343) with videos related to

Pageof 35
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
Measures to mitigate treatment-related toxicities in third-line metastatic colorectal cancerMichel Ducreux
Clinical and Experimental Gastroenterology|June 23, 2011
Developments in treating metastatic colorectal cancer: Recent international reports from ASCO 2007 and 2008Michel Ducreux
Soins; La Revue De Reference Infirmiere|December 23, 2019
[Oral treatments for cancer]Michel Ducreux
The Lancet. Oncology|February 28, 2017
Carcinoid syndrome in neuroendocrine tumors: a prognostic effect?Michel Ducreux
Gastroenterologie Clinique Et Biologique|March 28, 2006
[Clinical cases: a well-differentiated endocrine tumor]Michel Ducreux, Eric Baudin
The Lancet. Oncology|November 5, 2020
Results from the PROPHYLOCHIP-PRODIGE 15 trial - Authors' replyDiane Goéré, Michel Ducreux
Case Reports in Oncology|July 27, 2023
Case Report: Vision Loss Induced by Capecitabine in Patient with Preexisting Left Eyes BlindPaul Matte, Michel Ducreux
La Revue Du Praticien|April 17, 2004
[Colorectal cancer: contribution of new diagnostic tools]Clarisse Dromain, Michel Ducreux
La Revue Du Praticien|April 3, 2002
[Biotherapy of neuroendocrine tumors]Philippe Chanson, Michel Ducreux
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Bevacizumab and subtype-adapted chemotherapy backbone in neuroendocrine tumorsJulien Hadoux, Michel Ducreux
Pageof 35

Showing results (1-10 of 343) with videos related to

Sort By:
Pageof 35
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
Measures to mitigate treatment-related toxicities in third-line metastatic colorectal cancerMichel Ducreux
Clinical and Experimental Gastroenterology|June 23, 2011
Developments in treating metastatic colorectal cancer: Recent international reports from ASCO 2007 and 2008Michel Ducreux
Soins; La Revue De Reference Infirmiere|December 23, 2019
[Oral treatments for cancer]Michel Ducreux
The Lancet. Oncology|February 28, 2017
Carcinoid syndrome in neuroendocrine tumors: a prognostic effect?Michel Ducreux
Gastroenterologie Clinique Et Biologique|March 28, 2006
[Clinical cases: a well-differentiated endocrine tumor]Michel Ducreux, Eric Baudin
The Lancet. Oncology|November 5, 2020
Results from the PROPHYLOCHIP-PRODIGE 15 trial - Authors' replyDiane Goéré, Michel Ducreux
Case Reports in Oncology|July 27, 2023
Case Report: Vision Loss Induced by Capecitabine in Patient with Preexisting Left Eyes BlindPaul Matte, Michel Ducreux
La Revue Du Praticien|April 17, 2004
[Colorectal cancer: contribution of new diagnostic tools]Clarisse Dromain, Michel Ducreux
La Revue Du Praticien|April 3, 2002
[Biotherapy of neuroendocrine tumors]Philippe Chanson, Michel Ducreux
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Bevacizumab and subtype-adapted chemotherapy backbone in neuroendocrine tumorsJulien Hadoux, Michel Ducreux
Pageof 35